130 related articles for article (PubMed ID: 36266538)
21. Intraocular recurrence of uveal melanoma after proton beam irradiation.
Gragoudas ES; Egan KM; Seddon JM; Walsh SM; Munzenrider JE
Ophthalmology; 1992 May; 99(5):760-6. PubMed ID: 1594223
[TBL] [Abstract][Full Text] [Related]
22. Enucleation after Stereotactic Radiosurgery in Patients with Uveal Melanoma.
Zahorjanová P; Sekáč J; Babál P; Štubňa M
Cesk Slov Oftalmol; 2020; 76(1):46-51. PubMed ID: 32917094
[TBL] [Abstract][Full Text] [Related]
23. Ring melanoma of the anterior chamber angle: a report of fourteen cases.
Demirci H; Shields CL; Shields JA; Eagle RC; Honavar S
Am J Ophthalmol; 2001 Sep; 132(3):336-42. PubMed ID: 11530045
[TBL] [Abstract][Full Text] [Related]
24. Uveal tumour resection.
Char DH; Miller T; Crawford JB
Br J Ophthalmol; 2001 Oct; 85(10):1213-9. PubMed ID: 11567967
[TBL] [Abstract][Full Text] [Related]
25. Quality of life: fractionated stereotactic radiotherapy versus enucleation treatment in uveal melanoma patients.
van Beek JGM; Buitendijk GHS; Timman R; Muller K; Luyten GPM; Paridaens D; Naus NC; Kiliç E
Acta Ophthalmol; 2018 Dec; 96(8):841-848. PubMed ID: 30284368
[TBL] [Abstract][Full Text] [Related]
26. No demonstrated effect of pre-enucleation irradiation on survival of patients with uveal melanoma.
Luyten GP; Mooy CM; Eijkenboom WM; Stijnen T; Hellemons LP; Luider TM; de Jong PT
Am J Ophthalmol; 1995 Jun; 119(6):786-91. PubMed ID: 7785695
[TBL] [Abstract][Full Text] [Related]
27. Secondary Enucleations for Uveal Melanoma: A 7-Year Retrospective Analysis.
Fabian ID; Tomkins-Netzer O; Stoker I; Arora AK; Sagoo MS; Cohen VM
Am J Ophthalmol; 2015 Dec; 160(6):1104-1110.e1. PubMed ID: 26344583
[TBL] [Abstract][Full Text] [Related]
28. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
[TBL] [Abstract][Full Text] [Related]
29. Estimates of ocular and visual retention following treatment of extra-large uveal melanomas by proton beam radiotherapy.
Conway RM; Poothullil AM; Daftari IK; Weinberg V; Chung JE; O'Brien JM
Arch Ophthalmol; 2006 Jun; 124(6):838-43. PubMed ID: 16769837
[TBL] [Abstract][Full Text] [Related]
30. High dose rate and low dose rate ruthenium brachytherapy for uveal melanoma. No association with ocular outcome.
Fili M; Lundell G; Lundell M; Seregard S
Br J Ophthalmol; 2014 Oct; 98(10):1349-54. PubMed ID: 24825846
[TBL] [Abstract][Full Text] [Related]
31. Management of radiation-induced severe anophthalmic socket contracture in patients with uveal melanoma.
Nasser QJ; Gombos DS; Williams MD; Guadagnolo BA; Morrison WH; Garden AS; Beadle BM; Canseco E; Esmaeli B
Ophthalmic Plast Reconstr Surg; 2012; 28(3):208-12. PubMed ID: 22581085
[TBL] [Abstract][Full Text] [Related]
32. Fractionated stereotactic radiotherapy for uveal melanoma, late clinical results.
Muller K; Naus N; Nowak PJ; Schmitz PI; de Pan C; van Santen CA; Marijnissen JP; Paridaens DA; Levendag PC; Luyten GP
Radiother Oncol; 2012 Feb; 102(2):219-24. PubMed ID: 21864922
[TBL] [Abstract][Full Text] [Related]
33. Linear accelerator-based stereotactic fractionated photon radiotherapy as an eye-conserving treatment for uveal melanoma.
Akbaba S; Foerster R; Nicolay NH; Arians N; Bostel T; Debus J; Hauswald H
Radiat Oncol; 2018 Aug; 13(1):140. PubMed ID: 30071857
[TBL] [Abstract][Full Text] [Related]
34. Uveal melanoma: management and outcome of patients with extraocular spread.
Bellmann C; Lumbroso-Le Rouic L; Levy C; Plancher C; Dendale R; Sastre-Garau X; Asselain B; Desjardins L
Br J Ophthalmol; 2010 May; 94(5):569-74. PubMed ID: 19965816
[TBL] [Abstract][Full Text] [Related]
35. Ruthenium-106 plaque brachytherapy for thick posterior uveal melanomas.
Kaiserman N; Kaiserman I; Hendler K; Frenkel S; Pe'er J
Br J Ophthalmol; 2009 Sep; 93(9):1167-71. PubMed ID: 19570767
[TBL] [Abstract][Full Text] [Related]
36. 15 years experience with helium ion radiotherapy for uveal melanoma.
Castro JR; Char DH; Petti PL; Daftari IK; Quivey JM; Singh RP; Blakely EA; Phillips TL
Int J Radiat Oncol Biol Phys; 1997 Dec; 39(5):989-96. PubMed ID: 9392536
[TBL] [Abstract][Full Text] [Related]
37. No differences in outcome between radical surgical treatment (enucleation) and stereotactic radiosurgery in patients with posterior uveal melanoma.
Furdova A; Slezak P; Chorvath M; Waczulikova I; Sramka M; Kralik G
Neoplasma; 2010; 57(4):377-81. PubMed ID: 20429631
[TBL] [Abstract][Full Text] [Related]
38. Uveal melanoma: evaluation of extrascleral extension using thin-section MR of the eye with surface coils.
Tartaglione T; Pagliara MM; Sciandra M; Caputo CG; Calandrelli R; Fabrizi G; Gaudino S; Blasi MA; Colosimo C
Radiol Med; 2014 Oct; 119(10):775-83. PubMed ID: 24469990
[TBL] [Abstract][Full Text] [Related]
39. Uveal melanoma treated with iodine-125 episcleral plaque: an analysis of dose on disease control and visual outcomes.
Perez BA; Mettu P; Vajzovic L; Rivera D; Alkaissi A; Steffey BA; Cai J; Stinnett S; Dutton JJ; Buckley EG; Halperin E; Marks LB; Mruthyunjaya P; Kirsch DG
Int J Radiat Oncol Biol Phys; 2014 May; 89(1):127-36. PubMed ID: 24613808
[TBL] [Abstract][Full Text] [Related]
40. Pattern of Local Recurrence After I-125 Episcleral Brachytherapy for Uveal Melanoma in a Spanish Referral Ocular Oncology Unit.
Sánchez-Tabernero S; García-Alvarez C; Muñoz-Moreno MF; Diezhandino P; Alonso-Martínez P; de Frutos-Baraja JM; López-Lara F; Saornil MA
Am J Ophthalmol; 2017 Aug; 180():39-45. PubMed ID: 28572063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]